These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 1504150)

  • 1. Clinical trials of granulocyte-macrophage colony-stimulating factor for the treatment of aplastic anemia.
    Vadhan-Raj S
    Immunol Ser; 1992; 57():661-70. PubMed ID: 1504150
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical applications of human granulocyte-macrophage colony-stimulating factor.
    Sakamoto KM; Gasson JC
    Int J Cell Cloning; 1991 Nov; 9(6):531-41. PubMed ID: 1770227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte colony-stimulating factors.
    Med Lett Drugs Ther; 1991 Jun; 33(847):61-3. PubMed ID: 1710761
    [No Abstract]   [Full Text] [Related]  

  • 4. Methimazole-induced severe aplastic anemia: unsuccessful treatment with recombinant human granulocyte-monocyte colony-stimulating factor.
    Escobar-Morreale HF; Bravo P; García-Robles R; García-Laraña J; de la Calle H; Sancho JM
    Thyroid; 1997 Feb; 7(1):67-70. PubMed ID: 9086574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effect of stem cell factor on colony growth from acquired severe aplastic anemia.
    Bacigalupo A; Piaggio G; Podestá M; Raffo MR; Tedone E; Sogno G; Benvenuto F; Figari O; Grassia L; Bagnara GP
    Stem Cells; 1993 Jul; 11 Suppl 2():175-9. PubMed ID: 7691324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of colony stimulating factors in the treatment of aplastic anemia].
    Domingo Morera JM; Palomera Bernal L; Agulló Alcober JA; Olave Rubio MT
    Med Clin (Barc); 1994 Dec; 103(20):799. PubMed ID: 7532252
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of recombinant human granulocyte-macrophage colony-stimulating factor as treatment for aplastic anemia and agranulocytosis.
    Champlin RE; Nimer SD; Oette D; Golde DW
    Prog Clin Biol Res; 1990; 338():143-50. PubMed ID: 2189137
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro response of normal and aplastic anemia bone marrow to mast cell growth factor and in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3.
    Gibson FM; Scopes J; Daly S; Ball SE; Gordon-Smith EC
    Exp Hematol; 1994 Mar; 22(3):302-12. PubMed ID: 8112428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma lactoferrin content in neutropenic patients: effects of treatment with recombinant granulocyte-macrophage colony-stimulating factor.
    Bezwoda WR; Dajee D
    Mol Biother; 1992 Jun; 4(2):103-6. PubMed ID: 1515094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose cyclophosphamide in the treatment of severe aplastic anemia in children.
    Jaime-Pérez JC; González-Llano O; Gómez-Almaguer D
    Am J Hematol; 2001 Jan; 66(1):71. PubMed ID: 11426504
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of granulocyte-macrophage colony stimulating factor on paroxysmal nocturnal hemoglobinuria: a case report.
    Webb DI; Bundtzen JL
    Alaska Med; 1993; 35(3):216-7, 224. PubMed ID: 8109693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma.
    Hübel K; Dale DC; Liles WC
    J Infect Dis; 2002 May; 185(10):1490-501. PubMed ID: 11992286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic value of interleukin-3 given alone or in combination with other cytokines.
    Ganser A; Hoelzer D
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):245-6. PubMed ID: 8337137
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical use of hematopoietic growth factors].
    Krusius T
    Duodecim; 1990; 106(7):547-9. PubMed ID: 1727024
    [No Abstract]   [Full Text] [Related]  

  • 15. GM-CSF clinical trials: pediatric aplastic anemia and Fanconi's anemia.
    Lopez KD; Guinan EC
    Pediatr Nurs; 1995; 21(4):345-9. PubMed ID: 7644282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Emergency therapy with granulocyte-macrophage colony-stimulating factor (GM-CSF)].
    Gratwohl A; Dazzi H; Tichelli A; Stebler C; Wernli M; Thomssen C; Kim I; Dieterle A; Obrist R; Stern A
    Schweiz Med Wochenschr; 1991 Mar; 121(12):413-7. PubMed ID: 2028244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advances in the research of clinical use of recombinant human granulocyte colony-stimulating factors].
    Jiang FG; Geng JP; Yang CL
    Zhonghua Nei Ke Za Zhi; 1991 Nov; 30(11):723-5. PubMed ID: 1726145
    [No Abstract]   [Full Text] [Related]  

  • 18. Colony-stimulating factors: clinical status.
    Gabrilove JL
    Important Adv Oncol; 1991; ():215-37. PubMed ID: 1714420
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of granulocyte colony-stimulating factor for treatment of aplastic anemia.
    Kojima S
    Nagoya J Med Sci; 1999 Nov; 62(3-4):77-82. PubMed ID: 10689869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [GM-CSF and G-CSF: cytokines in clinical application].
    Ruef C; Coleman DL
    Schweiz Med Wochenschr; 1991 Mar; 121(12):397-412. PubMed ID: 1709294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.